Bio Rad Laboratories Stock Analysis
| BIO-B Stock | USD 336.00 3.36 0.99% |
Bio Rad Laboratories is overvalued with Real Value of 253.67 and Hype Value of 336.0. The main objective of Bio Rad stock analysis is to determine its intrinsic value, which is an estimate of what Bio Rad Laboratories is worth, separate from its market price. There are two main types of Bio Rad's stock analysis: fundamental analysis and technical analysis.
The Bio Rad stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Bio Rad's ongoing operational relationships across important fundamental and technical indicators.
Bio |
Bio Stock Analysis Notes
About 98.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.26. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bio Rad Laboratories has Price/Earnings To Growth (PEG) ratio of 1.21. The entity recorded a loss per share of 28.09. The firm had not issued any dividends in recent years. Bio Rad had 2:1 split on the 8th of March 2002. Bio-Rad Laboratories, Inc. develops, manufactures, and markets products and solutions for the life science research and clinical diagnostic markets in Europe, the Pacific Rim, the United States, and internationally. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. Bio Rad operates under Diagnostics Research classification in USA and is traded on New York Stock Exchange. It employs 8000 people. For more info on Bio Rad Laboratories please contact Norman Schwartz at 510 724 7000 or go to https://www.bio-rad.com.Bio Rad Quarterly Total Revenue |
|
Bio Rad Laboratories Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Bio Rad's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Bio Rad Laboratories or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Bio Rad Laboratories is not yet fully synchronised with the market data | |
| The company reported the revenue of 2.67 B. Net Loss for the year was (637.32 M) with profit before overhead, payroll, taxes, and interest of 1.57 B. | |
| About 98.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Disposition of 1682 shares by Cary Majors of STERIS Plc at 217.32 subject to Rule 16b-3 |
Bio Largest EPS Surprises
Earnings surprises can significantly impact Bio Rad's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
1993-02-12 | 1992-12-31 | 0.07 | 0.06 | -0.01 | 14 | ||
1994-02-09 | 1993-12-31 | 0.09 | 0.13 | 0.04 | 44 | ||
1993-04-28 | 1993-03-31 | 0.1 | 0.14 | 0.04 | 40 |
Bio Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.71 B.Bio Profitablity
The company has Profit Margin (PM) of (0.3) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.1 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.1.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.06) | (0.05) | |
| Return On Capital Employed | 0.03 | 0.03 | |
| Return On Assets | (0.05) | (0.05) | |
| Return On Equity | (0.07) | (0.07) |
Management Efficiency
Bio Rad Laboratories has return on total asset (ROA) of 0.0186 % which means that it generated a profit of $0.0186 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0979) %, meaning that it generated substantial loss on money invested by shareholders. Bio Rad's management efficiency ratios could be used to measure how well Bio Rad manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.05. In addition to that, Return On Capital Employed is expected to decline to 0.03. At present, Bio Rad's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 9.7 B, whereas Other Current Assets are forecasted to decline to about 92.3 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 299.26 | 314.22 | |
| Tangible Book Value Per Share | 274.13 | 287.84 | |
| Enterprise Value Over EBITDA | (17.15) | (16.29) | |
| Price Book Value Ratio | 1.08 | 2.15 | |
| Enterprise Value Multiple | (17.15) | (16.29) | |
| Price Fair Value | 1.08 | 2.15 | |
| Enterprise Value | 952.4 M | 1 B |
Leadership effectiveness at Bio Rad Laboratories is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin 0.0994 | Profit Margin (0.30) | Beta 0.936 | Return On Assets 0.0186 | Return On Equity (0.1) |
Bio Rad Laboratories Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bio Rad insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bio Rad's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bio Rad insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ajit Ramalingam over three months ago Disposition of tradable shares by Ajit Ramalingam of Bio-Rad Laboratories at 4.6 subject to Rule 16b-3 | ||
Timothy Ernst over six months ago Disposition of 253 shares by Timothy Ernst of Bio-Rad Laboratories subject to Rule 16b-3 | ||
Andrew Last over six months ago Disposition of 430 shares by Andrew Last of Bio-Rad Laboratories at 4.6 subject to Rule 16b-3 |
Bio Rad Outstanding Bonds
Bio Rad issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bio Rad Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bio bonds can be classified according to their maturity, which is the date when Bio Rad Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BIO 33 15 MAR 27 Corp BondUS090572AR99 | View | |
| BIO 37 15 MAR 32 Corp BondUS090572AQ17 | View | |
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Bio Rad Predictive Daily Indicators
Bio Rad intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bio Rad stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.0099 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 337.68 | |||
| Day Typical Price | 337.12 | |||
| Market Facilitation Index | 3.36 | |||
| Price Action Indicator | (3.36) | |||
| Period Momentum Indicator | (3.36) |
About Bio Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Bio Rad prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bio Rad. By using and applying Bio Stock analysis, traders can create a robust methodology for identifying Bio entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.32) | (0.30) | |
| Operating Profit Margin | 0.14 | 0.08 | |
| Net Loss | (0.24) | (0.23) | |
| Gross Profit Margin | 0.54 | 0.63 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Bio Rad to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Complementary Tools for Bio Stock analysis
When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |